WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
www.gsk.com
GlaxoSmithKline RSS Channel
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category GlaxoSmithKline
Title
Published Date
London 2012 partner, GlaxoSmithKline, shares scientific expertise with World Anti-Doping Agency
05 July 2011
GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
15 June 2011
GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)
13 June 2011
Millions of children in the world's poorest countries could receive vaccination against rotavirus diarrhoeal disease
09 June 2011
GSK forms partnership with three leading NGOs
25 May 2011
Pharmaceutical industry and university create Manchester Collaborative Centre for Inflammation Research
12 May 2011
GSK welcomes key agreement to support global preparedness against pandemic influenza
19 April 2011
GSK publishes payments for research, consulting and advising by US healthcare professionals
01 April 2011
GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
28 March 2011
GSK supports recovery efforts to help those affected by the Japan earthquake
20 March 2011
Start
Prev
7
8
9
10
11
12
13
14
15
16
Next
End
Business & Industry
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
Bayer Consumer Health leaders propose new principles for science-led self-care
GSK signs agreement to support pandemic preparedness in Europe
Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
Research & Development
New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19
Research identifies, exploits vulnerability in certain high-risk cancers
Scientists create long-acting injectable drug delivery system for tuberculosis
Treating cancer by sticking cells in place
Vitamin K prevents cell death: a new function for a long-known molecule
Disparities in United States COVID-19 vaccine distribution
New needle-free nasal vaccine shows promise for COVID-19
Conferences & Events
New approach to treatment of deadly kidney cancer
SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
SMi's 22nd Annual Pain Therapeutics Conference
SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
FDA approves first systemic treatment for alopecia areata
FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
FDA limits use of Janssen COVID-19 vaccine to certain individuals
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
FDA approves first generic of Symbicort to treat asthma and COPD
You are here:
Home
GlaxoSmithKline
GSK signs agreement to support pandemic preparedness in Europe